51
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Bone Marrow Is a Major Parasite Reservoir in Plasmodium vivax Infection

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Plasmodium vivax causes heavy burdens of disease across malarious regions worldwide. Mature P. vivax asexual and transmissive gametocyte stages occur in the blood circulation, and it is often assumed that accumulation/sequestration in tissues is not an important phase in their development. Here, we present a systematic study of P. vivax stage distributions in infected tissues of nonhuman primate (NHP) malaria models as well as in blood from human infections. In a comparative analysis of the transcriptomes of P. vivax and Plasmodium falciparum blood-stage parasites, we found a conserved cascade of stage-specific gene expression despite the greatly different gametocyte maturity times of these two species. Using this knowledge, we validated a set of conserved asexual- and gametocyte-stage markers both by quantitative real-time PCR and by antibody assays of peripheral blood samples from infected patients and NHP ( Aotus sp.). Histological analyses of P. vivax parasites in organs of 13 infected NHP ( Aotus and Saimiri species) demonstrated a major fraction of immature gametocytes in the parenchyma of the bone marrow, while asexual schizont forms were enriched to a somewhat lesser extent in this region of the bone marrow as well as in sinusoids of the liver. These findings suggest that the bone marrow is an important reservoir for gametocyte development and proliferation of malaria parasites.

          IMPORTANCE

          Plasmodium vivax malaria continues to cause major public health burdens worldwide. Yet, significant knowledge gaps in the basic biology and epidemiology of P. vivax malaria remain, largely due to limited available tools for research and diagnostics. Here, we present a systematic examination of tissue sequestration during P. vivax infection. Studies of nonhuman primates and malaria patients revealed enrichment of developing sexual stages (gametocytes) and mature replicative stages (schizonts) in the bone marrow and liver, relative to those present in peripheral blood. Identification of the bone marrow as a major P. vivax tissue reservoir has important implications for parasite diagnosis and treatment.

          Related collections

          Most cited references70

          • Record: found
          • Abstract: found
          • Article: not found

          Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

          Malaria remains a major cause of morbidity and mortality in the tropics, with Plasmodium falciparum responsible for the majority of the disease burden and P. vivax being the geographically most widely distributed cause of malaria. Gametocytes are the sexual-stage parasites that infect Anopheles mosquitoes and mediate the onward transmission of the disease. Gametocytes are poorly studied despite this crucial role, but with a recent resurgence of interest in malaria elimination, the study of gametocytes is in vogue. This review highlights the current state of knowledge with regard to the development and longevity of P. falciparum and P. vivax gametocytes in the human host and the factors influencing their distribution within endemic populations. The evidence for immune responses, antimalarial drugs, and drug resistance influencing infectiousness to mosquitoes is reviewed. We discuss how the application of molecular techniques has led to the identification of submicroscopic gametocyte carriage and to a reassessment of the human infectious reservoir. These components are drawn together to show how control measures that aim to reduce malaria transmission, such as mass drug administration and a transmission-blocking vaccine, might better be deployed.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found
            Is Open Access

            Comparative genomics of the neglected human malaria parasite Plasmodium vivax.

            The human malaria parasite Plasmodium vivax is responsible for 25-40% of the approximately 515 million annual cases of malaria worldwide. Although seldom fatal, the parasite elicits severe and incapacitating clinical symptoms and often causes relapses months after a primary infection has cleared. Despite its importance as a major human pathogen, P. vivax is little studied because it cannot be propagated continuously in the laboratory except in non-human primates. We sequenced the genome of P. vivax to shed light on its distinctive biological features, and as a means to drive development of new drugs and vaccines. Here we describe the synteny and isochore structure of P. vivax chromosomes, and show that the parasite resembles other malaria parasites in gene content and metabolic potential, but possesses novel gene families and potential alternative invasion pathways not recognized previously. Completion of the P. vivax genome provides the scientific community with a valuable resource that can be used to advance investigation into this neglected species.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Vivax malaria: neglected and not benign.

              Plasmodium vivax threatens almost 40% of the world's population, resulting in 132-391 million clinical infections each year. Most of these cases originate from Southeast Asia and the Western Pacific, although a significant number also occurs in Africa and South America. Although often regarded as causing a benign and self-limiting infection, there is increasing evidence that the overall burden, economic impact, and severity of disease from P. vivax have been underestimated. Malaria control strategies have had limited success and are confounded by the lack of access to reliable diagnosis, emergence of multidrug resistant isolates, the parasite's ability to transmit early in the course of disease and relapse from dormant liver stages at varying time intervals after the initial infection. Progress in reducing the burden of disease will require improved access to reliable diagnosis and effective treatment of both blood-stage and latent parasites, and more detailed characterization of the epidemiology, morbidity, and economic impact of vivax malaria. Without these, vivax malaria will continue to be neglected by ministries of health, policy makers, researchers, and funding bodies.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                mBio
                MBio
                mbio
                mbio
                mBio
                mBio
                American Society for Microbiology (1752 N St., N.W., Washington, DC )
                2150-7511
                8 May 2018
                May-Jun 2018
                : 9
                : 3
                : e00625-18
                Affiliations
                [a ]Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA
                [b ]Tropical Medicine Research, Panama City, Panama
                [c ]Instituto Conmemorativo Gorgas de Estudios de la Salud, Panama City, Panama
                [d ]Center for Excellence in Vascular Biology, Brigham and Women’s Hospital, Boston, Massachusetts, USA
                [e ]Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
                [f ]Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA
                [g ]Department of Parasitology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil
                [h ]Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts, USA
                [i ]Wellcome Centre for Molecular Parasitology, University of Glasgow, Glasgow, United Kingdom
                University of Pittsburgh
                Author notes
                Address correspondence to Matthias Marti, matthias.marti@ 123456glasgow.ac.uk .

                N.O. and E.M. are co-first authors.

                This article is a direct contribution from a Fellow of the American Academy of Microbiology. Solicited external reviewers: Clemens Kocken, Biomedical Primate Research Centre; Hernando Del Portillo, ISGlobal.

                Author information
                https://orcid.org/0000-0002-3832-8955
                https://orcid.org/0000-0003-1040-9566
                Article
                mBio00625-18
                10.1128/mBio.00625-18
                5941073
                29739900
                4017d5d1-692d-45b0-9f99-e70f06def13d
                Copyright © 2018 Obaldia et al.

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

                History
                : 3 April 2018
                : 11 April 2018
                Page count
                supplementary-material: 9, Figures: 4, Tables: 1, Equations: 0, References: 79, Pages: 16, Words: 12137
                Funding
                Funded by: US Army Medical Materiel Development Activity;
                Award ID: W81XWH-07-C-044
                Award Recipient :
                Funded by: Secretaria Nacional de Ciencia y Technologia - Instituto para la Formacion y Aprovechamiento de Recursos Humanos, Panama;
                Award Recipient :
                Funded by: Sistema Nacional de Investigacion of Panama;
                Award Recipient :
                Funded by: Wellcome Trust Centre Award;
                Award ID: 104111
                Award Recipient :
                Funded by: HHS | National Institutes of Health (NIH), https://doi.org/10.13039/100000002;
                Award ID: 1R01HL139337
                Award Recipient :
                Funded by: Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID), https://doi.org/10.13039/100006492;
                Award ID: ZIA AI000483
                Award Recipient :
                Categories
                Research Article
                Custom metadata
                May/June 2018

                Life sciences
                aotus,real-time pcr,saimiri,blood-stage parasites,gametocytes,immunohistochemistry,laboratory animal models,malaria,transcriptome

                Comments

                Comment on this article